FDx Advisors, Inc.

Position in AZN — Astrazeneca PLC

CIK 1566601 BERWYN, PA

Position in AZN

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$718,280

-$179,859 QoQ

Shares Held

3,788

-16.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.93%

of 13F equity value

Holder Rank

#750

of 1,459 holders

Holding Since

Mar 2026

2 quarters on record

Healthcare · as of Jun 30, 2026

FDx Advisors, Inc. holds $3,475,495 across 7 Drug Manufacturers - General names. AZN ranks #2 (20.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	5,362	$840,332
2	AZN	Astrazeneca PLC This page	3,788	$718,280
3	JNJ	Johnson & Johnson	2,062	$523,686
4	ABBV	AbbVie Inc.	1,988	$500,260
5	MRK	Merck & Co., Inc.	3,036	$390,126
6	SNY	Sanofi	5,911	$252,163
7	PFE	Pfizer Inc	10,409	$250,648

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$718,280	3,788	-16.8%	Shares	Sole	2026-08-04
2026-03-31	$898,139	4,554	—	Shares	Sole	2026-05-01
No filing history on record for this holder in this stock.